The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limb

G Molenaers, A Van Campenhout… - Journal of children's …, 2010 - journals.sagepub.com
Purpose The purpose of this review is to clarify the role of botulinum toxin serotype A (BTX-
A) in the treatment of children with cerebral palsy (CP), with a special focus on the lower …

Botulinum toxin A treatment of the lower extremities in children with cerebral palsy

G Molenaers, K Fagard… - Journal of children's …, 2013 - journals.sagepub.com
Objectives In the last 2 decades, BTX-A is increasingly being used in the management of
spasticity in children with Cerebral Palsy (CP) and there is no doubt about its effect on range …

Botulinum toxin and cerebral palsy: time for reflection?

M Gough, C Fairhurst… - … Medicine & Child …, 2005 - Wiley Online Library
Botulinum toxin A (BTX‐A) is increasingly being used in early management of spasticity in
ambulant children with cerebral palsy (CP), with the aim of improving function, promoting …

Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review

RN Boyd, RM Hays - European Journal of Neurology, 2001 - Wiley Online Library
Management of children with cerebral palsy (CP) is the focus of considerable resources in
many countries, so that evaluation of the efficacy for new and established treatments is …

Factors predicting the efficacy of botulinum toxin-A treatment of the lower limb in children with cerebral palsy

E Fazzi, I Maraucci, S Torrielli… - Journal of child …, 2005 - journals.sagepub.com
Botulinum toxin A is widely used for spasticity management in children with cerebral palsy,
although outcomes are unpredictable. The aim of this study was to identify criteria for …

[HTML][HTML] Botulinum toxin in the management of children with cerebral palsy

I Multani, J Manji, T Hastings-Ison, A Khot, K Graham - Pediatric Drugs, 2019 - Springer
During the past 25 years, botulinum toxin type A (BoNT-A) has become the most widely used
medical intervention in children with cerebral palsy. In this review we consider the gaps in …

[HTML][HTML] Botulinum toxin treatment for limb spasticity in childhood cerebral palsy

V Pavone, G Testa, DA Restivo, L Cannavò… - Frontiers in …, 2016 - frontiersin.org
CP is the most common cause of chronic disability in childhood occurring in 2–2.5/1000
births. It is a severe disorder and a significant number of patients present cognitive delay …

Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation

K Bjornson, R Hays, C Graubert, R Price, F Won… - …, 2007 - publications.aap.org
BACKGROUND. Spasticity is a prevalent disabling clinical symptom for children with
cerebral palsy. Treatment of spasticity with botulinum toxin in children with cerebral palsy …

[HTML][HTML] Best clinical practice in botulinum toxin treatment for children with cerebral palsy

W Strobl, T Theologis, R Brunner, S Kocer… - Toxins, 2015 - mdpi.com
Botulinum toxin A (BoNT-A) is considered a safe and effective therapy for children with
cerebral palsy (CP), especially in the hands of experienced injectors and for the majority of …

[HTML][HTML] Botulinum toxin intervention in cerebral palsy-induced spasticity management: projected and contradictory effects on skeletal muscles

CSK Keles, F Ates - Toxins, 2022 - ncbi.nlm.nih.gov
Spasticity, following the neurological disorder of cerebral palsy (CP), describes a
pathological condition, the central feature of which is involuntary and prolonged muscle …